Literature DB >> 21413053

Lack of respiratory improvement following remediation of a water-damaged office building.

Yulia Y Iossifova1, Jean M Cox-Ganser, Ju-Hyeong Park, Sandra K White, Kathleen Kreiss.   

Abstract

BACKGROUND: Damp buildings are commonly remediated without removing employees or ongoing medical surveillance.
METHODS: We examined paired pulmonary function and questionnaire data from 2002 and 2005 for 97 employees in a water-damaged building during ongoing but incomplete remediation.
RESULTS: We observed no overall improvement in respiratory health, as reflected in symptom scores, overall medication use, spirometry abnormalities, or sick leave. Four employees went from borderline bronchial hyperresponsiveness to bronchial hyperresponsiveness; six developed abnormal spirometry; three more reported post-occupancy current asthma, and four hypersensitivity pneumonitis. The number of participants without lower respiratory symptoms decreased from 27 in 2002 to 20 in 2005. Respiratory cases relocated in the building had a decrease in medication use and sick leave in 2005.
CONCLUSIONS: During dampness remediation, relocation may be health protective and prevent incident building-related respiratory cases. Without relocation of entire workforces, medical surveillance is advisable for secondary prevention of existing building-related disease.
Copyright © 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21413053     DOI: 10.1002/ajim.20910

Source DB:  PubMed          Journal:  Am J Ind Med        ISSN: 0271-3586            Impact factor:   2.214


  9 in total

1.  NIOSH's Respiratory Health Division: 50 years of science and service.

Authors:  Kristin J Cummings; Doug O Johns; Jacek M Mazurek; Frank J Hearl; David N Weissman
Journal:  Arch Environ Occup Health       Date:  2018-12-02       Impact factor: 1.663

Review 2.  Occupational causes of sarcoidosis.

Authors:  Kira L Newman; Lee S Newman
Journal:  Curr Opin Allergy Clin Immunol       Date:  2012-04

3.  Asthma related to workplace dampness and impaired work ability.

Authors:  Kirsi Karvala; Henrik Nordman; Ritva Luukkonen; Jukka Uitti
Journal:  Int Arch Occup Environ Health       Date:  2012-12-04       Impact factor: 3.015

Review 4.  Remediating buildings damaged by dampness and mould for preventing or reducing respiratory tract symptoms, infections and asthma.

Authors:  Riitta Sauni; Jos H Verbeek; Jukka Uitti; Merja Jauhiainen; Kathleen Kreiss; Torben Sigsgaard
Journal:  Cochrane Database Syst Rev       Date:  2015-02-25

5.  TLR9-dependent IL-23/IL-17 is required for the generation of Stachybotrys chartarum-induced hypersensitivity pneumonitis.

Authors:  Urvashi Bhan; Michael J Newstead; Xianying Zeng; Amy Podsaid; Moloy Goswami; Megan N Ballinger; Steven L Kunkel; Theodore J Standiford
Journal:  J Immunol       Date:  2012-11-23       Impact factor: 5.422

6.  Hypersensitivity pneumonitis in workers exposed to metalworking fluids.

Authors:  Christopher M Barber; Clare M Burton; David J Hendrick; C Anthony C Pickering; Alastair S Robertson; Wendy Robertson; P Sherwood Burge
Journal:  Am J Ind Med       Date:  2014-06-20       Impact factor: 2.214

7.  Generation and Characterization of Indoor Fungal Aerosols for Inhalation Studies.

Authors:  Anne Mette Madsen; Søren T Larsen; Ismo K Koponen; Kirsten I Kling; Afnan Barooni; Dorina Gabriela Karottki; Kira Tendal; Peder Wolkoff
Journal:  Appl Environ Microbiol       Date:  2016-04-04       Impact factor: 4.792

8.  Changes in respiratory and non-respiratory symptoms in occupants of a large office building over a period of moisture damage remediation attempts.

Authors:  Ju-Hyeong Park; Sook Ja Cho; Sandra K White; Jean M Cox-Ganser
Journal:  PLoS One       Date:  2018-01-11       Impact factor: 3.240

9.  Comparing cognitive-behavioural psychotherapy and psychoeducation for non-specific symptoms associated with indoor air: a randomised control trial protocol.

Authors:  Sanna Selinheimo; Aki Vuokko; Markku Sainio; Kirsi Karvala; Hille Suojalehto; Heli Järnefelt; Tiina Paunio
Journal:  BMJ Open       Date:  2016-06-06       Impact factor: 2.692

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.